Nasdaq Atra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned a consensus recommendation of “Hold” from the three research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 12-month price objective among brokerages that have updated their coverage on the stock in […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 11,030,000 shares, a growth of 8.8% from the February 29th total of 10,140,000 shares. Based on an average daily volume of 3,500,000 shares, […]

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been given an average recommendation of “Hold” by the three research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation. The average twelve-month target price among brokers that have issued ratings on the […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has received an average recommendation of “Hold” from the four research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year target price […]

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned a consensus rating of “Hold” from the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month […]